Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to 2.02.

  • Zevra Therapeutics' Interest Coverage Ratio rose 11710.33% to 2.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 10.66, marking a year-over-year increase of 2732.1%. This contributed to the annual value of 11.84 for FY2024, which is 6418.61% up from last year.
  • According to the latest figures from Q3 2025, Zevra Therapeutics' Interest Coverage Ratio is 2.02, which was up 11710.33% from 35.36 recorded in Q2 2025.
  • Zevra Therapeutics' Interest Coverage Ratio's 5-year high stood at 364.56 during Q2 2021, with a 5-year trough of 689.31 in Q2 2022.
  • For the 5-year period, Zevra Therapeutics' Interest Coverage Ratio averaged around 103.52, with its median value being 31.74 (2023).
  • Over the last 5 years, Zevra Therapeutics' Interest Coverage Ratio had its largest YoY gain of 1672920.6% in 2021, and its largest YoY loss of 3540681.51% in 2021.
  • Zevra Therapeutics' Interest Coverage Ratio (Quarter) stood at 568.4 in 2021, then soared by 90.54% to 53.78 in 2022, then surged by 62.72% to 20.05 in 2023, then skyrocketed by 64.95% to 7.03 in 2024, then surged by 128.75% to 2.02 in 2025.
  • Its last three reported values are 2.02 in Q3 2025, 35.36 for Q2 2025, and 2.72 during Q1 2025.